Mesenchymal stem cells (Qilu Cell Therapy)

间充质干细胞（齐鲁细胞）

Report date: 2025/04/02 13:36:22

Base Information

Drug NameMesenchymal stem cells (Qilu Cell Therapy)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Gitelman SyndromeRickets, Hypophosphatemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Qilu Cell Treapy Engineering&Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Provincial HospitalShandong Qilu Stem Cells Engineering Co LtdTongji Hospital Tongji Of Huazhong University Of Science & Technology, China
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Gitelman SyndromeRickets, Hypophosphatemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A